chr17-58308997-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004758.4(TSPOAP1):c.4275A>T(p.Arg1425=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 1,612,302 control chromosomes in the GnomAD database, including 70,073 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 6642 hom., cov: 33)
Exomes 𝑓: 0.29 ( 63431 hom. )
Consequence
TSPOAP1
NM_004758.4 synonymous
NM_004758.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.03
Genes affected
TSPOAP1 (HGNC:16831): (TSPO associated protein 1) Enables benzodiazepine receptor binding activity. Predicted to be involved in regulation of presynaptic cytosolic calcium ion concentration. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 17-58308997-T-A is Benign according to our data. Variant chr17-58308997-T-A is described in ClinVar as [Benign]. Clinvar id is 1294164.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSPOAP1 | NM_004758.4 | c.4275A>T | p.Arg1425= | synonymous_variant | 22/32 | ENST00000343736.9 | |
TSPOAP1 | NM_001261835.2 | c.4275A>T | p.Arg1425= | synonymous_variant | 22/32 | ||
TSPOAP1 | NM_024418.3 | c.4095A>T | p.Arg1365= | synonymous_variant | 21/31 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSPOAP1 | ENST00000343736.9 | c.4275A>T | p.Arg1425= | synonymous_variant | 22/32 | 1 | NM_004758.4 | P2 | |
TSPOAP1 | ENST00000268893.10 | c.4095A>T | p.Arg1365= | synonymous_variant | 21/31 | 1 | A2 | ||
TSPOAP1 | ENST00000580669.6 | c.1671A>T | p.Arg557= | synonymous_variant | 6/16 | 5 | |||
TSPOAP1 | ENST00000582679.1 | c.421+970A>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.295 AC: 44850AN: 152032Hom.: 6630 Cov.: 33
GnomAD3 genomes
AF:
AC:
44850
AN:
152032
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.282 AC: 69485AN: 246376Hom.: 10058 AF XY: 0.283 AC XY: 37946AN XY: 134270
GnomAD3 exomes
AF:
AC:
69485
AN:
246376
Hom.:
AF XY:
AC XY:
37946
AN XY:
134270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.293 AC: 427995AN: 1460152Hom.: 63431 Cov.: 60 AF XY: 0.291 AC XY: 211713AN XY: 726396
GnomAD4 exome
AF:
AC:
427995
AN:
1460152
Hom.:
Cov.:
60
AF XY:
AC XY:
211713
AN XY:
726396
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.295 AC: 44886AN: 152150Hom.: 6642 Cov.: 33 AF XY: 0.294 AC XY: 21894AN XY: 74388
GnomAD4 genome
AF:
AC:
44886
AN:
152150
Hom.:
Cov.:
33
AF XY:
AC XY:
21894
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
763
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at